T he study by Lafata et al. evaluated whether medication adherence mediated racial disparities in achieving HBA1c, LDL or SBP targets among diabetics. 1 The authors found that blacks had poorer medication adherence compared to whites in all three classes of medications, and were less likely to achieve clinical targets. Racial disparities persisted in multivariable models that included medication adherence and treatment intensification. The strengths of the study are the inclusion of patients from multiple sites and the use of objective adherence and outcome data. A limitation was the use of an adherence definition that required having at least two prescriptions filled, since the exclusion of subjects with no or one refill could have introduced bias.
Other investigators have reported persistent disparities in cardiovascular outcomes between black and white subjects after adjusting for variables such as adherence, income, education, or burden of disease. 2 This study highlights the complexity of the factors influencing disparities in health outcomes, which are diverse and dynamic and include a range of environmental exposures that shape beliefs, behaviors and interactions with the health system. 3 The authors appropriately advocate the systematic evaluation of multiple types of barriers among subjects not reaching quality targets. This is important, since improvements in quality of care have not eliminated disparities. Chin et al. concluded that reducing disparities requires six key steps which include making equity a priority of quality improvement efforts and designing interventions based on the local root causes. 4 The patient-centered model of care may facilitate this individualized approach and should be a focus of future research. In the meantime, we must be careful in how we interpret the evidence. Factors such as medication adherence, depression, health literacy, or income play a role, though don't completely explain differences in clinical outcomes among minorities.
